PTH-045 Integrated Alcohol And Hepatology Mdt: Reducing Alcohol-related Hospital Admission And Attendance

K Mannix(Broadgreen Hospital), Paul Richardson(University of Liverpool), Lynn Owens(University of North Carolina at Chapel Hill), S puravady(Royal Liverpool and Broadgreen University Hospital NHS Trust), L. Richardson(Royal Liverpool and Broadgreen University Hospital NHS Trust), Kev Patterson(University of Liverpool)
Gut
June 1, 2014
10.1136/gutjnl-2014-307263.491
Cited by 0

Related Papers

Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine
|Journal of Hepatology|2000|205
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial
|The Lancet HIV|2020|177
Severe hepatitis E infection during pregnancy
|Journal of Viral Hepatitis|1997|144
Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease
|Clinical Science|2015|138
A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study
|The Lancet|2018|97